Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation. [electronic resource]
Producer: 20160719Description: 26052-64 p. digitalISSN:- 1949-2553
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Bile Duct Neoplasms -- genetics
- Blotting, Western
- Cell Line, Tumor
- Cholangiocarcinoma -- genetics
- Cisplatin -- pharmacology
- Deoxycytidine -- analogs & derivatives
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Leukemia Inhibitory Factor -- genetics
- Leukemia Inhibitory Factor Receptor alpha Subunit -- genetics
- Microscopy, Fluorescence
- Myeloid Cell Leukemia Sequence 1 Protein -- metabolism
- Phosphatidylinositol 3-Kinases -- metabolism
- Proto-Oncogene Proteins c-akt -- metabolism
- RNA Interference
- Reverse Transcriptase Polymerase Chain Reaction
- Signal Transduction -- drug effects
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.